 Lisa Abuogi
Concepts (158)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV Infections | 47 | 2025 | 2719 | 8.290 |
Why?
| | Infectious Disease Transmission, Vertical | 22 | 2025 | 170 | 5.860 |
Why?
| | Anti-HIV Agents | 20 | 2025 | 754 | 5.730 |
Why?
| | Kenya | 32 | 2025 | 107 | 4.060 |
Why?
| | Pregnancy Complications, Infectious | 12 | 2025 | 367 | 3.130 |
Why?
| | Anti-Retroviral Agents | 9 | 2024 | 231 | 2.190 |
Why?
| | Breast Feeding | 8 | 2024 | 423 | 2.150 |
Why?
| | Medication Adherence | 8 | 2025 | 556 | 1.820 |
Why?
| | Sexual Partners | 7 | 2023 | 185 | 1.740 |
Why?
| | Viral Load | 10 | 2025 | 448 | 1.730 |
Why?
| | Pregnant Women | 7 | 2023 | 114 | 1.500 |
Why?
| | Text Messaging | 4 | 2023 | 149 | 1.460 |
Why?
| | Qualitative Research | 7 | 2024 | 1215 | 1.410 |
Why?
| | Pregnancy | 26 | 2025 | 6390 | 1.380 |
Why?
| | Intimate Partner Violence | 3 | 2021 | 82 | 1.260 |
Why?
| | Infant | 27 | 2024 | 8975 | 1.220 |
Why?
| | Mothers | 7 | 2022 | 730 | 1.180 |
Why?
| | Peripartum Period | 2 | 2024 | 16 | 1.100 |
Why?
| | Social Support | 5 | 2024 | 582 | 1.100 |
Why?
| | Spouses | 4 | 2020 | 100 | 0.980 |
Why?
| | Focus Groups | 4 | 2024 | 450 | 0.970 |
Why?
| | Prenatal Care | 4 | 2020 | 274 | 0.960 |
Why?
| | HIV-1 | 2 | 2023 | 836 | 0.900 |
Why?
| | Fathers | 1 | 2023 | 49 | 0.830 |
Why?
| | Female | 45 | 2025 | 68551 | 0.810 |
Why?
| | Peer Group | 2 | 2024 | 225 | 0.810 |
Why?
| | Patient Navigation | 1 | 2024 | 78 | 0.810 |
Why?
| | Social Stigma | 7 | 2025 | 117 | 0.800 |
Why?
| | Interviews as Topic | 3 | 2024 | 705 | 0.770 |
Why?
| | Postpartum Period | 6 | 2024 | 332 | 0.740 |
Why?
| | Fertilization | 1 | 2021 | 42 | 0.700 |
Why?
| | Zambia | 4 | 2023 | 54 | 0.700 |
Why?
| | Mentors | 3 | 2021 | 178 | 0.680 |
Why?
| | Young Adult | 16 | 2024 | 12391 | 0.650 |
Why?
| | Humans | 53 | 2025 | 129266 | 0.650 |
Why?
| | Sustained Virologic Response | 1 | 2018 | 37 | 0.600 |
Why?
| | Continuity of Patient Care | 1 | 2020 | 272 | 0.590 |
Why?
| | Motivation | 1 | 2022 | 546 | 0.570 |
Why?
| | Health Facilities | 2 | 2021 | 79 | 0.560 |
Why?
| | Adult | 24 | 2025 | 35495 | 0.550 |
Why?
| | Health Facility Administration | 1 | 2017 | 6 | 0.550 |
Why?
| | Community Health Services | 2 | 2019 | 226 | 0.540 |
Why?
| | Truth Disclosure | 1 | 2017 | 44 | 0.540 |
Why?
| | Spouse Abuse | 1 | 2017 | 40 | 0.530 |
Why?
| | Infant, Newborn | 10 | 2024 | 5736 | 0.500 |
Why?
| | Reminder Systems | 1 | 2018 | 173 | 0.500 |
Why?
| | Patient Dropouts | 1 | 2016 | 64 | 0.500 |
Why?
| | Male | 26 | 2024 | 63512 | 0.490 |
Why?
| | Adolescent | 17 | 2024 | 20313 | 0.490 |
Why?
| | Health Resources | 1 | 2016 | 113 | 0.480 |
Why?
| | Child | 20 | 2023 | 20785 | 0.480 |
Why?
| | Tuberculosis | 2 | 2014 | 273 | 0.430 |
Why?
| | Point-of-Care Systems | 3 | 2023 | 147 | 0.410 |
Why?
| | Patient Compliance | 1 | 2016 | 563 | 0.390 |
Why?
| | Treatment Failure | 2 | 2023 | 339 | 0.340 |
Why?
| | Randomized Controlled Trials as Topic | 4 | 2025 | 1365 | 0.290 |
Why?
| | Child, Preschool | 8 | 2022 | 10459 | 0.290 |
Why?
| | Practice Guidelines as Topic | 2 | 2024 | 1497 | 0.280 |
Why?
| | Developing Countries | 2 | 2021 | 284 | 0.270 |
Why?
| | Case-Control Studies | 3 | 2018 | 3377 | 0.250 |
Why?
| | Prospective Studies | 4 | 2023 | 7123 | 0.240 |
Why?
| | Retrospective Studies | 8 | 2024 | 14461 | 0.230 |
Why?
| | Colorado | 3 | 2023 | 4406 | 0.220 |
Why?
| | Dried Blood Spot Testing | 1 | 2024 | 94 | 0.220 |
Why?
| | RNA, Viral | 2 | 2024 | 619 | 0.210 |
Why?
| | Prevalence | 3 | 2024 | 2553 | 0.210 |
Why?
| | Lactation | 1 | 2024 | 169 | 0.210 |
Why?
| | Infant Health | 1 | 2023 | 24 | 0.210 |
Why?
| | United States | 4 | 2024 | 13826 | 0.210 |
Why?
| | Maternal Health | 1 | 2023 | 45 | 0.210 |
Why?
| | Proportional Hazards Models | 4 | 2024 | 1197 | 0.200 |
Why?
| | Drug Resistance, Viral | 1 | 2023 | 110 | 0.200 |
Why?
| | CD4 Lymphocyte Count | 2 | 2024 | 266 | 0.200 |
Why?
| | Risk Factors | 4 | 2021 | 9745 | 0.200 |
Why?
| | Patient Acceptance of Health Care | 2 | 2019 | 757 | 0.190 |
Why?
| | DNA, Viral | 1 | 2024 | 349 | 0.190 |
Why?
| | Telephone | 1 | 2023 | 167 | 0.190 |
Why?
| | Drug Resistance | 1 | 2022 | 166 | 0.190 |
Why?
| | Treatment Outcome | 5 | 2021 | 10202 | 0.180 |
Why?
| | Cross-Sectional Studies | 4 | 2020 | 5050 | 0.180 |
Why?
| | Emigrants and Immigrants | 1 | 2023 | 121 | 0.180 |
Why?
| | Organophosphates | 1 | 2022 | 120 | 0.180 |
Why?
| | Mass Screening | 2 | 2020 | 1149 | 0.180 |
Why?
| | Public Health Surveillance | 1 | 2021 | 68 | 0.180 |
Why?
| | Treatment Adherence and Compliance | 1 | 2021 | 24 | 0.180 |
Why?
| | Asymptomatic Infections | 1 | 2020 | 26 | 0.180 |
Why?
| | Transition to Adult Care | 1 | 2022 | 79 | 0.170 |
Why?
| | Reward | 1 | 2022 | 240 | 0.170 |
Why?
| | Infant, Low Birth Weight | 1 | 2021 | 135 | 0.170 |
Why?
| | Health Personnel | 2 | 2023 | 648 | 0.170 |
Why?
| | Adenine | 1 | 2022 | 256 | 0.170 |
Why?
| | Symptom Assessment | 1 | 2021 | 125 | 0.170 |
Why?
| | Patient Participation | 1 | 2023 | 414 | 0.170 |
Why?
| | Acquired Immunodeficiency Syndrome | 1 | 2021 | 227 | 0.160 |
Why?
| | Ambulatory Care | 1 | 2023 | 504 | 0.160 |
Why?
| | Hospitals | 1 | 2023 | 630 | 0.150 |
Why?
| | C-Reactive Protein | 1 | 2021 | 400 | 0.150 |
Why?
| | Disclosure | 1 | 2019 | 110 | 0.150 |
Why?
| | Odds Ratio | 1 | 2021 | 1019 | 0.150 |
Why?
| | Pregnancy Outcome | 1 | 2021 | 389 | 0.150 |
Why?
| | Emotions | 1 | 2023 | 538 | 0.150 |
Why?
| | Research Design | 1 | 2023 | 1043 | 0.140 |
Why?
| | Diagnostic Tests, Routine | 1 | 2018 | 102 | 0.140 |
Why?
| | Self Disclosure | 1 | 2017 | 62 | 0.140 |
Why?
| | HIV | 1 | 2018 | 226 | 0.140 |
Why?
| | Disease Management | 1 | 2021 | 588 | 0.140 |
Why?
| | Decision Making | 1 | 2024 | 849 | 0.130 |
Why?
| | Multicenter Studies as Topic | 1 | 2018 | 285 | 0.130 |
Why?
| | HIV Seropositivity | 1 | 2017 | 119 | 0.130 |
Why?
| | Health Knowledge, Attitudes, Practice | 3 | 2024 | 1276 | 0.130 |
Why?
| | Rural Population | 2 | 2017 | 513 | 0.130 |
Why?
| | Comorbidity | 1 | 2021 | 1544 | 0.130 |
Why?
| | Marriage | 1 | 2017 | 113 | 0.130 |
Why?
| | Hospitalization | 2 | 2023 | 2052 | 0.120 |
Why?
| | Attitude of Health Personnel | 2 | 2024 | 1094 | 0.110 |
Why?
| | Health Services Research | 1 | 2017 | 390 | 0.110 |
Why?
| | Isoniazid | 1 | 2014 | 63 | 0.110 |
Why?
| | Biomarkers | 2 | 2024 | 3968 | 0.110 |
Why?
| | Cohort Studies | 3 | 2024 | 5409 | 0.100 |
Why?
| | Severity of Illness Index | 1 | 2021 | 2740 | 0.100 |
Why?
| | Incidence | 2 | 2022 | 2636 | 0.100 |
Why?
| | Antitubercular Agents | 1 | 2014 | 200 | 0.100 |
Why?
| | Mutation | 1 | 2022 | 3710 | 0.090 |
Why?
| | Surveys and Questionnaires | 2 | 2020 | 5384 | 0.090 |
Why?
| | Delivery of Health Care | 1 | 2018 | 892 | 0.090 |
Why?
| | Nasopharynx | 2 | 2022 | 67 | 0.090 |
Why?
| | Depression | 1 | 2020 | 1306 | 0.090 |
Why?
| | Prognosis | 1 | 2018 | 3773 | 0.080 |
Why?
| | Logistic Models | 1 | 2013 | 1985 | 0.070 |
Why?
| | Time Factors | 1 | 2018 | 6543 | 0.070 |
Why?
| | Consultants | 1 | 2024 | 13 | 0.060 |
Why?
| | Observation | 1 | 2024 | 51 | 0.060 |
Why?
| | Cerebrospinal Fluid | 1 | 2024 | 91 | 0.050 |
Why?
| | North America | 1 | 2023 | 291 | 0.050 |
Why?
| | Point-of-Care Testing | 1 | 2022 | 32 | 0.050 |
Why?
| | Milk, Human | 1 | 2023 | 151 | 0.050 |
Why?
| | Africa, Northern | 1 | 2021 | 4 | 0.050 |
Why?
| | Adaptive Immunity | 1 | 2022 | 161 | 0.040 |
Why?
| | Trust | 1 | 2022 | 115 | 0.040 |
Why?
| | Professional-Patient Relations | 1 | 2022 | 138 | 0.040 |
Why?
| | Oropharynx | 1 | 2020 | 43 | 0.040 |
Why?
| | Income | 1 | 2021 | 188 | 0.040 |
Why?
| | Cognitive Dysfunction | 1 | 2024 | 346 | 0.040 |
Why?
| | Principal Component Analysis | 1 | 2020 | 190 | 0.040 |
Why?
| | Family Characteristics | 1 | 2020 | 178 | 0.040 |
Why?
| | Mental Health | 1 | 2025 | 685 | 0.040 |
Why?
| | House Calls | 1 | 2019 | 123 | 0.040 |
Why?
| | Delivery, Obstetric | 1 | 2018 | 136 | 0.030 |
Why?
| | Poverty | 1 | 2021 | 496 | 0.030 |
Why?
| | Gene Expression | 1 | 2022 | 1466 | 0.030 |
Why?
| | Hospitals, Pediatric | 1 | 2020 | 508 | 0.030 |
Why?
| | Telemedicine | 1 | 2024 | 788 | 0.030 |
Why?
| | Risk Assessment | 1 | 2025 | 3232 | 0.030 |
Why?
| | Pandemics | 1 | 2023 | 1481 | 0.030 |
Why?
| | Program Evaluation | 1 | 2017 | 872 | 0.030 |
Why?
| | Reproducibility of Results | 1 | 2020 | 3080 | 0.020 |
Why?
| | Aged | 1 | 2022 | 22032 | 0.010 |
Why?
| | Middle Aged | 1 | 2017 | 31090 | 0.010 |
Why?
|
|
Abuogi's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|